Embla Medical hf Resultados de beneficios anteriores
Pasado controles de criterios 4/6
Los beneficios de Embla Medical hf han disminuido a una tasa media anual de -5.1%, mientras que en la industria Medical Equipment los beneficios crecieron en un 5.1% anualmente. Los ingresos han ido creciendo a una tasa media de 4.2% al año. La rentabilidad financiera de Embla Medical hf es de 7.8%, y sus márgenes netos son de 7.1%.
Información clave
-5.1%
Tasa de crecimiento de los beneficios
-5.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | -1.7% |
| Tasa de crecimiento de los ingresos | 4.2% |
| Rentabilidad financiera | 7.8% |
| Margen neto | 7.1% |
| Próxima actualización de resultados | 23 Jul 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings
May 14
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?
Jan 26Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain
Jan 08
We're Watching These Trends At Össur hf (CPH:OSSR)
Dec 21Desglose de ingresos y gastos
Cómo gana y gasta dinero Embla Medical hf. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 24 | 804 | 57 | 368 | 38 |
| 31 Dec 23 | 786 | 58 | 360 | 38 |
| 30 Sep 23 | 766 | 52 | 353 | 37 |
| 30 Jun 23 | 750 | 45 | 354 | 36 |
| 31 Mar 23 | 730 | 43 | 345 | 34 |
| 31 Dec 22 | 719 | 43 | 339 | 34 |
| 30 Sep 22 | 715 | 47 | 339 | 34 |
| 30 Jun 22 | 719 | 57 | 331 | 33 |
| 31 Mar 22 | 728 | 62 | 331 | 34 |
| 31 Dec 21 | 719 | 64 | 328 | 32 |
| 30 Sep 21 | 701 | 50 | 323 | 32 |
| 30 Jun 21 | 692 | 48 | 318 | 31 |
| 31 Mar 21 | 637 | 11 | 308 | 31 |
| 31 Dec 20 | 630 | 6 | 307 | 31 |
| 30 Sep 20 | 639 | 20 | 303 | 30 |
| 30 Jun 20 | 635 | 19 | 308 | 30 |
| 31 Mar 20 | 680 | 59 | 311 | 31 |
| 31 Dec 19 | 686 | 66 | 308 | 31 |
| 30 Sep 19 | 675 | 83 | 296 | 31 |
| 30 Jun 19 | 652 | 85 | 284 | 31 |
| 31 Mar 19 | 631 | 83 | 274 | 31 |
| 31 Dec 18 | 613 | 80 | 265 | 31 |
| 30 Sep 18 | 599 | 69 | 259 | 31 |
| 30 Jun 18 | 593 | 64 | 254 | 31 |
| 31 Mar 18 | 579 | 58 | 252 | 30 |
| 31 Dec 17 | 569 | 58 | 245 | 29 |
| 30 Sep 17 | 553 | 49 | 246 | 29 |
| 30 Jun 17 | 543 | 51 | 239 | 27 |
| 31 Mar 17 | 538 | 52 | 240 | 25 |
| 31 Dec 16 | 521 | 51 | 233 | 23 |
| 30 Sep 16 | 507 | 49 | 227 | 21 |
| 30 Jun 16 | 495 | 50 | 219 | 20 |
| 31 Mar 16 | 483 | 51 | 209 | 19 |
| 31 Dec 15 | 483 | 51 | 208 | 18 |
| 30 Sep 15 | 488 | 54 | 209 | 18 |
| 30 Jun 15 | 497 | 55 | 213 | 18 |
| 31 Mar 15 | 502 | 57 | 214 | 19 |
| 31 Dec 14 | 509 | 59 | 218 | 19 |
| 30 Sep 14 | 509 | 58 | 217 | 20 |
| 30 Jun 14 | 487 | 55 | 207 | 20 |
| 31 Mar 14 | 460 | 46 | 199 | 21 |
| 31 Dec 13 | 436 | 40 | 189 | 22 |
| 30 Sep 13 | 406 | 35 | 178 | 22 |
| 30 Jun 13 | 400 | 33 | 177 | 23 |
Ingresos de calidad: EMBLA tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (7.1%) de EMBLA son superiores a los del año pasado (6%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de EMBLA han disminuido en un 5.1% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de EMBLA en el último año (31%) supera su media de 5 años (-5.1% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de EMBLA en el último año (31%) superó al de la industria Medical Equipment -0.04%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de EMBLA (7.8%) se considera baja.